ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $227,000 | -51.7% | 8,800 | 0.0% | 0.25% | -55.8% |
| Q4 2020 | $470,000 | +95.8% | 8,800 | +51.2% | 0.57% | +69.5% |
| Q3 2020 | $240,000 | -16.4% | 5,821 | -1.7% | 0.34% | -18.9% |
| Q2 2020 | $287,000 | +14.8% | 5,921 | 0.0% | 0.42% | -2.6% |
| Q1 2020 | $250,000 | -10.4% | 5,921 | -9.2% | 0.43% | +22.3% |
| Q4 2019 | $279,000 | +31.6% | 6,521 | +10.5% | 0.35% | +21.1% |
| Q3 2019 | $212,000 | -72.4% | 5,900 | -79.4% | 0.29% | -67.8% |
| Q2 2019 | $767,000 | -9.9% | 28,700 | -9.5% | 0.90% | +24.4% |
| Q1 2019 | $851,000 | +60.9% | 31,700 | -3.1% | 0.72% | +50.8% |
| Q4 2018 | $529,000 | -47.5% | 32,700 | -32.6% | 0.48% | -41.1% |
| Q3 2018 | $1,007,000 | +23.3% | 48,500 | -9.3% | 0.81% | +21.0% |
| Q2 2018 | $817,000 | -47.3% | 53,500 | -22.5% | 0.67% | -49.2% |
| Q1 2018 | $1,550,000 | -30.6% | 69,000 | -6.9% | 1.32% | -28.6% |
| Q4 2017 | $2,233,000 | -19.2% | 74,150 | +1.1% | 1.85% | -20.1% |
| Q3 2017 | $2,763,000 | +34.1% | 73,350 | -0.7% | 2.31% | +29.7% |
| Q2 2017 | $2,060,000 | -17.4% | 73,850 | +1.8% | 1.78% | -19.1% |
| Q1 2017 | $2,494,000 | +19.2% | 72,550 | 0.0% | 2.20% | +14.3% |
| Q4 2016 | $2,092,000 | -5.4% | 72,550 | +4.3% | 1.93% | -7.4% |
| Q3 2016 | $2,212,000 | -2.8% | 69,550 | -0.8% | 2.08% | -6.6% |
| Q2 2016 | $2,275,000 | +10.3% | 70,100 | -5.0% | 2.23% | -7.1% |
| Q1 2016 | $2,063,000 | -7.3% | 73,800 | +18.3% | 2.40% | -3.7% |
| Q4 2015 | $2,225,000 | +41.5% | 62,400 | +31.2% | 2.49% | +43.7% |
| Q3 2015 | $1,572,000 | -6.4% | 47,550 | +18.6% | 1.74% | +5.8% |
| Q2 2015 | $1,679,000 | +156.3% | 40,100 | +99.5% | 1.64% | +168.0% |
| Q1 2015 | $655,000 | +75.6% | 20,100 | +71.1% | 0.61% | +81.1% |
| Q4 2014 | $373,000 | +5.7% | 11,750 | -17.5% | 0.34% | -4.2% |
| Q3 2014 | $353,000 | +8.3% | 14,250 | -1.4% | 0.35% | +16.5% |
| Q2 2014 | $326,000 | +11.3% | 14,450 | +19.9% | 0.30% | +7.4% |
| Q1 2014 | $293,000 | -3.6% | 12,050 | -0.8% | 0.28% | -1.7% |
| Q4 2013 | $304,000 | – | 12,150 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |